Studio City Rehabilitation Center
STUDIO CITY REHABILITATION CENTER in STUDIO CITY, CA — inspection on August 23, 2024.
Found 3 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
During a review of Resident 126's Medication Administration Record ([MAR] - a record of mediations administered to residents,) for August 2024, the MAR indicated Resident 126 was prescribed Melatonin 5 mg to give one tablet by mouth at bedtime for supplement, at 9 PM.
During a review of Resident 126's Care Plan, initiated 7/8/24, the Care Plan indicated a goal of sleep of 6 hours per night.
During a review of the facility's Consultant Pharmacist's (CP) Medication Regimen Review ([MRR] - a thorough evaluation of the medication regimen of a resident, with the goal of promoting positive outcomes and minimizing adverse consequences and potential risks associated with medication,) document review dated 6/26/24, the document indicated Resident has been on order for Melatonin 5 mg qhs (at bedtime) for supplement.
Please consider changing the indication of Melatonin use to: 'for supplement to regulate Circadian rhythm.' Also consider monitor for 'hours of sleep qPM (at evening) and qNOC (at bedtime) shifts' to facilitate drug therapy monitoring.
The column marked 'Follow-Through, was empty and did not contain any documentation, dates, or signatures for the review of the CP's recommendations.
555686
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 555686 B.
Wing 08/23/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Studio City Rehabilitation Center 11429 Ventura Blvd Studio City, CA 91604
During a review of Resident 116's Admission Record, the Admission Record indicated the facility admitted the resident on 5/23/2024, with diagnoses including type 2 diabetes mellitus (a condition that happens because of a problem in the way the body regulates and uses sugar as fuel), acute kidney failure (when the body suddenly lose their ability to function), and urinary tract infection (a condition in which bacteria invade and grow in the urinary tract).
During a review of Resident 116's History and Physical (H&P), dated 5/24/2024, the H&P indicated the resident did not have the capacity to understand and make decisions.
During a review of Resident 116's Minimum Data Set (MDS, a standardized assessment and care screening tool), dated 5/30/2024, the MDS indicated the resident rarely to never had the ability to make self-understood and understand others.
The MDS indicated the resident was on a high-risk drug class hypoglycemic (medication that lowers blood sugar) (including insulin).
During a review of Resident 116's Order Summary Report, dated 5/25/2024, the report indicated an order for:
555686
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 555686 B.
Wing 08/23/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Studio City Rehabilitation Center 11429 Ventura Blvd Studio City, CA 91604
During a review of Resident 116's Admission Record, the Admission Record indicated the facility admitted the resident on 5/23/2024, with diagnoses including type 2 diabetes mellitus (a condition that happens because of a problem in the way the body regulates and uses sugar as fuel), acute kidney failure (when the body suddenly lose their ability to function), and urinary tract infection (a condition in which bacteria invade and grow in the urinary tract).
During a review of Resident 116's History and Physical (H&P), dated 5/24/2024, the H&P indicated the resident did not have the capacity to understand and make decisions.
During a review of Resident 116's Minimum Data Set (MDS, a standardized assessment and care screening tool), dated 5/30/2024, the MDS indicated the resident rarely to never had the ability to make self-understood and understand others.
The MDS indicated the resident was on a high-risk drug class hypoglycemic (medication that lowers blood sugar) (including insulin).
During a review of Resident 116's Order Summary Report, dated 5/25/2024, the report indicated an order for:
- insulin regular human injection solution (Insulin Regular [Human]) Inject as per sliding scale (varies the dose of insulin based on blood sugar level): if 61-150= 0. If blood sugar (BS) less than (<) 60 may administer 8 ounces (oz., a unit of weight measurement) orange juice and call MD; 151-200= 2; 201-250= 4; 251-300= 6; 301-350= 8; 351-399= 10; 400+ If BS greater than (>) 400, administer12 units (the amount required to lower the blood sugar) and notify MD, subcutaneously every 6 hours for diabetes mellitus (DM) rotate site.
555686
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 555686 B.
Wing 08/23/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
Studio City Rehabilitation Center 11429 Ventura Blvd Studio City, CA 91604